These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 21872822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M, Smith R, Lessnick SL.
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [Abstract] [Full Text] [Related]

  • 3. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
    Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL.
    Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
    [Abstract] [Full Text] [Related]

  • 4. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M, Smith R, Iyer AK, McCabe ER, Lessnick SL.
    Cancer Res; 2009 Dec 01; 69(23):9047-55. PubMed ID: 19920188
    [Abstract] [Full Text] [Related]

  • 5. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW, Basse AN, Chandler GL, Kirk AM, Rakheja D, Amatruda JF.
    Dis Model Mech; 2012 Jan 01; 5(1):95-106. PubMed ID: 21979944
    [Abstract] [Full Text] [Related]

  • 6. [Ewing's tumours, genetic and cellular aspects].
    Delattre O.
    Pathol Biol (Paris); 2008 Jul 01; 56(5):257-9. PubMed ID: 18485618
    [Abstract] [Full Text] [Related]

  • 7. The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma.
    Boone MA, Taslim C, Crow JC, Selich-Anderson J, Byrum AK, Showpnil IA, Sunkel BD, Wang M, Stanton BZ, Theisen ER, Lessnick SL.
    Oncogene; 2021 Jul 01; 40(29):4759-4769. PubMed ID: 34145397
    [Abstract] [Full Text] [Related]

  • 8. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
    Jully B, Vijayalakshmi R, Gopal G, Sabitha K, Rajkumar T.
    BMC Cancer; 2012 Nov 12; 12():513. PubMed ID: 23145994
    [Abstract] [Full Text] [Related]

  • 9. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
    Gangwal K, Lessnick SL.
    Cell Cycle; 2008 Oct 12; 7(20):3127-32. PubMed ID: 18927503
    [Abstract] [Full Text] [Related]

  • 10. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
    Yang L, Hu HM, Zielinska-Kwiatkowska A, Chansky HA.
    Biochem Biophys Res Commun; 2010 Nov 05; 402(1):129-34. PubMed ID: 20933505
    [Abstract] [Full Text] [Related]

  • 11. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N, Suvà ML, Suvà D, Cironi L, Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V, Stamenkovic I.
    Cancer Res; 2008 Apr 01; 68(7):2176-85. PubMed ID: 18381423
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C, Uluoğlu O, Akyürek N, Oğuz A, Karadeniz C.
    Pathol Oncol Res; 2011 Sep 01; 17(3):619-25. PubMed ID: 21267687
    [Abstract] [Full Text] [Related]

  • 13. AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells.
    Kitagawa T, Kobayashi D, Baron B, Okita H, Miyamoto T, Takai R, Paudel D, Ohta T, Asaoka Y, Tokunaga M, Nakagawa K, Furutani-Seiki M, Araki N, Kuramitsu Y, Kobayashi M.
    PLoS One; 2022 Sep 01; 17(10):e0269077. PubMed ID: 36194562
    [Abstract] [Full Text] [Related]

  • 14. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
    Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer TA.
    Am J Surg Pathol; 1999 Feb 01; 23(2):159-65. PubMed ID: 9989842
    [Abstract] [Full Text] [Related]

  • 15. Microsatellites as EWS/FLI response elements in Ewing's sarcoma.
    Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, Boucher KM, Watkins WS, Jorde LB, Graves BJ, Lessnick SL.
    Proc Natl Acad Sci U S A; 2008 Jul 22; 105(29):10149-54. PubMed ID: 18626011
    [Abstract] [Full Text] [Related]

  • 16. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
    Kim S, Denny CT, Wisdom R.
    Mol Cell Biol; 2006 Apr 22; 26(7):2467-78. PubMed ID: 16537893
    [Abstract] [Full Text] [Related]

  • 17. Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors.
    Tanaka M, Yamazaki Y, Kanno Y, Igarashi K, Aisaki K, Kanno J, Nakamura T.
    J Clin Invest; 2014 Jul 22; 124(7):3061-74. PubMed ID: 24911143
    [Abstract] [Full Text] [Related]

  • 18. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
    Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, Lessnick SL.
    Oncogene; 2013 Oct 17; 32(42):5089-100. PubMed ID: 23178492
    [Abstract] [Full Text] [Related]

  • 19. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H, Notario V.
    Cancer Res; 2006 Oct 15; 66(20):9937-47. PubMed ID: 17047056
    [Abstract] [Full Text] [Related]

  • 20. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
    Winter GE, Rix U, Lissat A, Stukalov A, Müllner MK, Bennett KL, Colinge J, Nijman SM, Kubicek S, Kovar H, Kontny U, Superti-Furga G.
    Mol Cancer Ther; 2011 Oct 15; 10(10):1846-56. PubMed ID: 21768330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.